NRP-1/CD304 expression in acute leukemia

American Journal of Clinical Pathology

Volumn 137, Issue 1, 2012, Pages 39-50

  Meyerson, Howard J ^a   Blidaru, Georgetta ^a   Edinger, Alison ^a   Osei, Ebenezer ^a   Schweitzer, Karen ^a   Fu, Pingfu ^b   Ho, Linda ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myeloid leukemia; CD304; Minimal residual disease; Neuropilin 1; Precursor B cell acute lymphoblastic leukemia

Indexed keywords

NEUROPILIN 1; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL TYPE; CHILD; CYTOGENETICS; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; LYMPHOID PROGENITOR CELL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BONE MARROW CELLS; DENDRITIC CELLS; ERYTHROBLASTS; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASM, RESIDUAL; NEUROPILIN-1; PLASMA CELLS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; TUMOR MARKERS, BIOLOGICAL;

EID: 84855255308     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP6VDBL4BRXRQA     Document Type: Article

References (23)

1. Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165:6037-6046.
2. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell. 1997;90:739- 751.
3. Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoformspecific receptor for vascular endothelial growth factor. Cell. 1998;92:735-745. (Pubitemid 28155313)
4. Takashima S, Kitakaze M, Asakura M, et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A. 2002;99:3657-3662. (Pubitemid 34252162)
5. Takamatsu H, Takegahara N, Nakagawa Y, et al. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol. 2010;11:594-600.
6. Tordjman R, Lepelletier Y, Lemarchandel V, et al. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol. 2002;3:477-482. (Pubitemid 34520798)
7. Belaid Z, Hubint F, Humblet C, et al. Differential expression of vascular endothelial growth factor and its receptors in hematopoietic and fatty bone marrow: evidence that neuropilin-1 is produced by fat cells. Haematologica. 2005;90:400-401. (Pubitemid 40388990)
8. Yamada Y, Oike Y, Ogawa H, et al. Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood. 2003;101:1801-1809. (Pubitemid 36237577)
9. Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004;34:623-630. (Pubitemid 39255909)
10. Milpied P, Renand A, Bruneau J, et al. Neuropilin-1 is not a marker of human Foxp3+ Treg. Eur J Immunol. 2009;39:1466-1471.
11. Karjalainen K, Jaalouk DE, Bueso-Ramos CE, et al. Targeting neuropilin-1 in human leukemia and lymphoma. Blood. 2011;117:920-927.
12. Lu L, Zhang L, Xiao Z, et al. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma. 2008;49:331-338. (Pubitemid 351193927)
13. Vales A, Kondo R, Aichberger KJ, et al. Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leuk Lymphoma. 2007;48:1997-2007. (Pubitemid 47542987)
14. Kreuter M, Steins M, Woelke K, et al. Downregulation of neuropilin-1 in patients with acute myeloid leukemia treated with thalidomide. Eur J Haematol. 2007;79:392-397. (Pubitemid 47556495)
15. Kreuter M, Woelke K, Bieker R, et al. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia. 2006;20:1950-1954. (Pubitemid 44614883)
16. Reineks EZ, Osei ES, Rosenberg A, et al. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometry B Clin Cytom. 2009;76:237-248.
17. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001;97:3210-3217.
18. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature, and the other immature. Immunology. 1994;82:487- 493.
19. Rossignol M, Gagnon ML, Klagsbrun M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics. 2000;70:211-222. (Pubitemid 32003398)
20. Coustan-Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia [published online ahead of print April 12, 2011]. Blood. 2011;117:6267-6276. doi:10.1182/blood-2010-12- 324004.
21. Dzionek A, Inagaki Y, Okawa K, et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol. 2002;63:1133-1148. (Pubitemid 36025988)
22. Ji JD, Park-Min KH, Ivashkiv LB. Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Hum Immunol. 2009;70:211-217.
23. de Paulis A, Prevete N, Fiorentino I, et al. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol. 2006;177:7322-7331. (Pubitemid 44715102)